Rare
lephants
Screener
Toggle theme
ARS Pharmaceuticals, Inc.
SPRY
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2024
3.1%
3.1%
2.3%
FY2025
-149.9%
-81.3%
-52.3%
Download CSV
